• What’s
    Your Focus
    • Develop Anti-Aging Interventions
    • Validate and Expand Health Claims
    • Target Age-Related Diseases
    • Study the Biology of Aging
    • Ensure the Safety of Your Products
    • I want to start working with NAMs
  • Products &
    Assays
    • Organism-on-Chip technology
    • SydLab™ One Platform
    • Nagi™ B-Age
    • Consumables & Reagents
    • SydLab™ Analyzer Software Modules
    • SydLab™ One Discovery Pack
  • Contract
    Research Services
    • Aging and Longevity Studies
    • Neurodegenerative Studies
    • Toxicity Studies
    • Compound Efficacy Studies
    • Microbiome Studies
    • Custom Studies
  • Applications
    • Fundamental Research
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Candidate Discovery
      • Aging and age-related Diseases
      • Neurodegenerative Diseases
    • Safety Toxicology
      • Developmental and Reproductive Toxicity
  • Resources
    • Resource Center
    • Nagi Blog
  • About Nagi
    • Our story
    • News
    • Events
    • Careers
  • Contact us
NAGI™ Users Hub
  • LinkedIn
  • X
  • RNA interference (RNAi) in C. elegans: A powerful tool for gene function and therapeutic discovery

    November 3, 2025
  • Investigating caloric restriction (CR) effects on Alzheimer’s Disease (AD) progression: A C. elegans model study with SydLab™ One and Nagi™ B-Age

    Alzheimer’s disease (AD), the most common form of dementia, is an age-related disease strongly associated with mitochondrial dysfunction and metabolic imbalance, both of which accelerate cellular and neuronal decline. Mitochondrial dysfunction, such…

    September 23, 2025
  • Early in vivo insights for therapeutic discovery in neurodegeneration

    January 24, 2025
  • Automated longitudinal monitoring of in vivo protein aggregation in neurodegenerative disease C. elegans models.

    Background While many biological studies can be performed on cell-based systems, the investigation of molecular pathways related to complex human dysfunctions – e.g. neurodegenerative diseases – often requires long-term studies in animal models. The…

    March 13, 2023
  • TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington’s disease models.

    Phosphorylation of the N-terminal domain of the huntingtin (HTT) protein has emerged as an important regulator of its localization, structure, aggregation, clearance and toxicity. However, validation of the effect of bona fide…

    March 13, 2023
    • LinkedIn
    • X

Contact

Nagi Bioscience SA
EPFL Innovation Park (M)
Rue des Jordils 1A
1025 Saint-Sulpice, Switzerland
Email: info@nagibio.ch

Links

  • Contract Laboratories Solutions
  • Applications
  • Industries
  • Resources
  • About Nagi
  • Contact Us

Legal

  • Change Cookie Settings
  • Terms and Conditions
  • Privacy Policy

© 2025 Nagi Bioscience • All rights reserved